LZAGY Stock: Lonza Group AG Stock Price, Analysis & Insights
Get live LZAGY stock price $61.78, comprehensive Lonza Group AG stock analysis, charts, news, and expert forecast. Real-time LZAGY stock data and investment insights.
Loading chart data...
Lonza Group AG (LZAGY) Overview
Lonza Group AG (LZAGY) is a publicly traded company in the Healthcare sector , specifically within the Medical - Diagnostics & Research industry . As of the latest trading session, LZAGY trades at $61.78 with a market capitalization of 43.96B . Over the past 52 weeks, LZAGY has traded between $58.53 and $73.85 , with the current price positioned at approximately 21% of this range . The stock cu...
Key Takeaways
- Operates in the Healthcare sector (Medical - Diagnostics & Research)
- Market cap: 43.96B
- Current price: $61.78
- 52-week range: $58.53 - $73.85
- P/E ratio: 37.90
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Lonza Group AG, along with its various affiliates, provides a comprehensive array of offerings for the pharmaceutical, biotechnology, and nutrition industries. Its global operations extend across Europe, North and Central America, Latin America, Asia...
Company Information
- CEO
- Wolfgang Wienand
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 17995
Contact Information
- Website
- https://www.lonza.com
- Address
- Muenchensteinerstrasse 38
- Country
- CH
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 37.9)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Lonza Group AG shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Lonza Group AG
- ⚠Investors should consider how Lonza Group AG fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 37.9) requires strong growth to justify
Market Cap
43.96B
P/E Ratio (TTM)
37.90
Beta
0.83
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare LZAGY with peer companies:
- Price
- $885.00
- Market cap
- 54.77B
- Price
- $0.00
- Market cap
- 6.66K
- Price
- $15.42
- Market cap
- 28.06B
- Price
- $4.51
- Market cap
- 39.78B
- Price
- $170.92
- Market cap
- 57.18B
- Price
- $46.75
- Market cap
- 61.82B
- Price
- $311.89
- Market cap
- 59.37B
- Price
- $151.73
- Market cap
- 57.77B
- Price
- $15.22
- Market cap
- 43.80B
- Price
- $14.78
- Market cap
- 44.09B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.